SQSTM1 and thyroid cancer: Consistent with the findings of Wang et al. [31], Run et al. [42] showed that vemurafenib treatment induced autophagy in thyroid cancer cells based on increases in Beclin1 and the LCII/I ratio as well as p62/SQSM1 degradation.